These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 631880)

  • 1. Use of an alkali-soluble water-soluble extract of Blastomyces dermatitidis yeast-phase cell walls and isoelectrically focused components in peripheral lymphocyte transformations.
    Hall NK; Deighton F; Larsh HW
    Infect Immun; 1978 Feb; 19(2):411-5. PubMed ID: 631880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo and in vitro cell-mediated immune responses to a cell wall antigen of Blastomyces dermatitidis.
    Deighton F; Cox RA; Hall NK; Larsh HW
    Infect Immun; 1977 Feb; 15(2):429-35. PubMed ID: 321349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of a purified skin test antigen from Blastomyces dermatitidis yeast-phase cell wall.
    Lancaster MV; Sprouse RF
    Infect Immun; 1976 Sep; 14(3):623-5. PubMed ID: 965086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blastomyces dermatitidis antigen-induced lymphocytes reactivity in human blastomycosis.
    Bradsher RW; Alford RH
    Infect Immun; 1981 Aug; 33(2):485-90. PubMed ID: 7024130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of skin test-active preparations from yeast-phase cells of Blastomyces dermatitidis.
    Cox RA; Larsh HW
    Infect Immun; 1974 Jul; 10(1):42-7. PubMed ID: 4135392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of antibodies and delayed dermal hypersensitivity with different lots of Blastomyces dermatitidis yeast lysate antigen: stability and specificity evaluations.
    Wakamoto A; Fryer BM; Fisher MA; Johnson TJ; Lundgren DK; Knickerbocker JD; Rounds SL; Scalarone GM
    Mycoses; 1997 Nov; 40(7-8):303-8. PubMed ID: 9476514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of antibodies and delayed hypersensitivity with Rotofor preparative IEF fractions of Blastomyces dermatitidis yeast phase lysate antigen.
    Bono JL; Legendre AM; Scalarone GM
    J Med Vet Mycol; 1995; 33(4):209-14. PubMed ID: 8531017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WI-1, a novel 120-kilodalton surface protein on Blastomyces dermatitidis yeast cells, is a target antigen of cell-mediated immunity in human blastomycosis.
    Klein BS; Sondel PM; Jones JM
    Infect Immun; 1992 Oct; 60(10):4291-300. PubMed ID: 1383148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-reactivity between antigens of Coccidioides immitis, Histoplasma capsulatum and Blastomyces dermatitidis in lymphocyte transformation assays.
    Cox RA
    Infect Immun; 1979 Sep; 25(3):932-8. PubMed ID: 500193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of antibody responses and delayed dermal hypersensitivity with Blastomyces dermatitidis yeast and mycelial lysate antigens.
    Seawell BW; Wheeler JY; Yearsley K; Alexander KL; Legendre AM; Scalarone GM
    Mycopathologia; 1991 Jun; 114(3):137-44. PubMed ID: 1886639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo and in virto cellular responses to cytoplasmic and cell wall antigens of Histoplasma capsulatum in artificially immunized or infected guinea pigs.
    Domer JE
    Infect Immun; 1976 Mar; 13(3):790-9. PubMed ID: 773825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoelectric focusing and ELISA evaluation of a Blastomyces dermatitidis human isolate.
    Shurley JF; Scalarone GM
    Mycopathologia; 2007 Aug; 164(2):73-6. PubMed ID: 17578679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative studies on the detection of antibodies and delayed hypersensitivity responses with 10 Blastomyces dermatitidis lysate antigens.
    Wakamoto A; Abuodeh RO; Scalarone GM
    Mycoses; 1997 Oct; 40(5-6):147-52. PubMed ID: 9476480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Blastomyces dermatitidis antigen in patients with newly diagnosed blastomycosis.
    Bariola JR; Hage CA; Durkin M; Bensadoun E; Gubbins PO; Wheat LJ; Bradsher RW
    Diagn Microbiol Infect Dis; 2011 Feb; 69(2):187-91. PubMed ID: 21251563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative studies on the detection of delayed dermal hypersensitivity in experimental animals with lysate and filtrate antigens of Blastomyces dermatitidis.
    Abuodeh RO; Scalarone GM
    Mycoses; 1994; 37(5-6):149-53. PubMed ID: 7898509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological and chemical characterization of glycoproteins in IEF fractions of Blastomyces dermatitidis yeast lysate antigen.
    Fisher MA; Legendre AM; Scalarone GM
    Mycoses; 1997 Sep; 40(3-4):83-90. PubMed ID: 9375492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin sensitivity of human beings to Histoplasma capsulatum and Blastomyces dermatitidis polysaccharide antigens.
    EDWARDS PQ; KNIGHT RA; MARCUS S
    Am Rev Respir Dis; 1961 Apr; 83():528-34. PubMed ID: 13725815
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative serological evaluation of 10 Blastomyces dermatitidis yeast phase lysate antigens from different sources.
    Abuodeh RO; Chester EM; Scalarone GM
    Mycoses; 2004 Apr; 47(3-4):143-9. PubMed ID: 15078431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polysaccharide skin test antigens derived from Histoplasma capsulatum and Blastomyces dermatitidis.
    KNIGHT RA; MARCUS S
    Am Rev Tuberc; 1958 Jun; 77(6):983-9. PubMed ID: 13533816
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization and evaluation of a soluble antigen complex prepared from the yeast phase of Histoplasma capsulatum.
    Reeves MW; Pine L; Bradley G
    Infect Immun; 1974 Jun; 9(6):1033-44. PubMed ID: 4208527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.